Kurma Life Science Partners is a venture capital firm that is interested in financing companies in healthcare and biotechnology industries. The firm was founded by Thierry Laugel in 2009, in Paris, Ile-de-France, and operates in the European Union.
The firm is interested in investing in companies that develop therapeutic and medical innovations in Europe. The firm also works with research institutions and hospitals to develop medical technologies. The firm has interest in companies that develop micro sensors, artificial intelligence, and cloud technology.
AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.
Documentaries, videos and podcasts
- Venture capitalA form of financing or funding for emerging companies. Investment on early-stage companies in exchange for equity in the companies they invest in.
- HealthcareDiagnosis, treatment and prevention of disease, illness, and injury
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.